Source: Investing.com ↗

Camp4 Therapeutics at Cantor conference: pushing first SYNGAP1 trial

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

+0.00%

BTC/USDT

$67,308.52

-1.50%

ETH/USDT

$1,905.93

-0.60%

SOL/USDT

$75.92

-3.74%

USD1/USDT

$0.9988

-0.06%